Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Oct 2026, 03:35
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
VALIANTLAB's 26.39% gross margin accelerated to, up from 22.9%.
The company's .9% marginal operating leverage also accelerated. Meanwhile, daily trading volume increased to . Additionally, the stock price rose to .75 INR, up from .65 INR. Revenue growth slowed to .2%, down from .2%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 26.39 % | 22.9 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 22.9 % | 5.24 | ▲ |
| REVENUE_GROWTH_YOY | 146.2 % | 826.2 | ▼ |
| PRICE_CHANGE_PERCENT | 4.53 % | — | - |
| DAILY_VOLUME | 1,96,125 shares | 1,22,015 | ▲ |
| CLOSE_PRICE | 140.75 INR | 134.65 | ▲ |
Cite this
Source: Samhati evidence synthesis for VALIANTLAB (2026-10-21). Observation: VALIANTLAB's 26.39% gross margin accelerated to, up from 22.9%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/valiantlab
Filing step-changes